Surely, even you don't think Blinatumomab will be doing the heavy lifting in killing these "target less" cancer cell otherwise they would be doing clinical trial to capture this massive cancer market.
Honestly.
Ann: First Australian Patient Dosed in Phase 1b azer-cel Trial, page-224
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
-0.002(10.0%) |
Mkt cap ! $104.5M | |||
| Open | High | Low | Value | Volume |
| 1.5¢ | 1.5¢ | 1.3¢ | $220.8K | 15.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 15595357 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 1057251 | 15 |
View Market Depth
| Last trade - 13.47pm 17/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |